T. Rowe Price Associates’s Aptevo Therapeutics APVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-46,200
| Closed | -$16K | – | 2905 |
|
|
2023
Q3 | $16K | Hold |
46,200
| – | – | ﹤0.01% | 2856 |
|
|
2023
Q2 | $68K | Hold |
46,200
| – | – | ﹤0.01% | 2758 |
|
|
2023
Q1 | $95K | Hold |
46,200
| – | – | ﹤0.01% | 2695 |
|
|
2022
Q4 | $107K | Hold |
46,200
| – | – | ﹤0.01% | 2703 |
|
|
2022
Q3 | $141K | Hold |
46,200
| – | – | ﹤0.01% | 2642 |
|
|
2022
Q2 | $165K | Hold |
46,200
| – | – | ﹤0.01% | 2641 |
|
|
2022
Q1 | $271K | Hold |
46,200
| – | – | ﹤0.01% | 2577 |
|
|
2021
Q4 | $364K | Buy |
+46,200
| New | +$364K | ﹤0.01% | 2522 |
|
|
2021
Q1 | – | Sell |
-6,300
| Closed | -$231K | – | 2840 |
|
|
2020
Q4 | $231K | Buy |
+6,300
| New | +$231K | ﹤0.01% | 2518 |
|
|
2017
Q4 | – | Sell |
-20,500
| Closed | -$47K | – | 2549 |
|
|
2017
Q3 | $47K | Hold |
20,500
| – | – | ﹤0.01% | 2530 |
|
|
2017
Q2 | $42K | Sell |
20,500
-40
| -0.2% | -$82 | ﹤0.01% | 2533 |
|
|
2017
Q1 | $42K | Hold |
20,540
| – | – | ﹤0.01% | 2546 |
|
|
2016
Q4 | $50K | Hold |
20,540
| – | – | ﹤0.01% | 2519 |
|
|
2016
Q3 | $53K | Buy |
+20,540
| New | +$53K | ﹤0.01% | 2493 |
|